Sangamo Therapeutics, Inc. · NASDAQ:SGMO

Armistice Capital, LLC reported a 9.38% stake in Sangamo Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Armistice Capital, LLC reported a 9.38% stake in Sangamo Therapeutics, Inc., 38,860,819 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
9.38%
Shares
38,860,819
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Armistice Capital, LLC9.38%38,860,819
Steven Boyd9.38%38,860,819

Source

View original at SEC

Related